Abstract In Shifting the focus from open release of genetically modified mosquitoes, to controlled individualized treatment for infectious diseases

As. Pac. J. Mol. Biol. & Biotech., Dec 2012 Vol. 20 (4)

In Shifting the focus from open release of genetically modified mosquitoes, to controlled individualized treatment for infectious diseases

Dziedzom K. de Souza¹, Samuel Dadzie¹, Joseph H. N. Osei¹, Daniel A. Boakye¹ and Takashi Suzuki^{1, 2}

¹Parasitology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
²Tokyo Medical and Dental University, Tokyo, Japan.

* Author for correspondence: Dziedzom K. de Souza
Parasitology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra-Ghana
Email : This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract.

Genetically modified (GM) vectors offer an opportunity for the control of many infectious diseases including malaria and dengue. However, they face issues of ethical consent, public and social acceptance and environmental concerns. Thus, strategies are needed to address these concerns before GM mosquitoes could be openly released. One example, the use of GM mosquitoes as “Flying Vaccinators” that have been designed to produce vaccine candidates, may provide some solutions to the concerns raised against GM vectors.

[Get pdf]